$1,000 – $3,000 Paid Clinical Trials
440 studies
Standard inpatient Phase 1 studies with multi-day residential stays typically compensate $1,000–$3,000.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 181–200 of 440 studies
Recruiting
Phase 1
Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers
Healthy Volunteer
Traws Pharma, Inc.24 enrolled1 locationNCT07526506
Recruiting
Phase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels
Healthy Participants
AstraZeneca40 enrolled1 locationNCT07423598
Recruiting
Phase 1
A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers
Healthy Male Participants
Biocon Biologics UK PLC150 enrolled1 locationNCT07299955
Recruiting
Phase 1
A Study of MK-7240 in Healthy Participants (MK-7240-009)
Healthy
Merck Sharp & Dohme LLC330 enrolled2 locationsNCT07405177
Recruiting
Phase 1
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
Healthy Participant
Pfizer8 enrolled1 locationNCT07153159
Recruiting
Phase 1
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
Healthy VolunteersHepatic Steatosis
Novo Nordisk A/S48 enrolled1 locationNCT06891365
Recruiting
Phase 1
A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants
Healthy Volunteers
Genentech, Inc.48 enrolled2 locationsNCT07329972
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants
Healthy Volunteers
Meiji Pharma USA Inc.104 enrolled1 locationNCT07422207
Recruiting
Phase 1
The ENHANCE Study: taVNS and Psilocybin
HealthyVagus Nerve StimulationPsychedelic Experiences
University of Wisconsin, Madison108 enrolled1 locationNCT05866471
Recruiting
Phase 1
Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet Formulation
Healthy
Abivax S.A.44 enrolled1 locationNCT07453784
Recruiting
Phase 1
A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
Healthy Participants
Pfizer24 enrolled4 locationsNCT07231991
Recruiting
Phase 1
A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People
Healthy
Boehringer Ingelheim106 enrolled1 locationNCT06575400
Recruiting
Phase 1
A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
Rheumatoid ArthritisHealthy VolunteersSystemic Lupus Erythematosus
Capstan Therapeutics64 enrolled1 locationNCT06917742
Recruiting
Phase 1Phase 2
Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers
Healthy Volunteers
ANRS, Emerging Infectious Diseases48 enrolled7 locationsNCT07113106
Recruiting
Phase 1
A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults
HealthyHealthy ParticipantsHealthy Adult Male+2 more
Dragonfly Therapeutics48 enrolled1 locationNCT07232121
Recruiting
Phase 1
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants
Healthy Participants
AstraZeneca32 enrolled1 locationNCT07444424
Recruiting
Phase 1
A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)
Healthy
Merck Sharp & Dohme LLC28 enrolled1 locationNCT07435194
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects
Healthy
Basilea Pharmaceutica136 enrolled1 locationNCT07500181
Recruiting
Phase 1
A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
Healthy
Merck Sharp & Dohme LLC39 enrolled1 locationNCT07431866
Recruiting
Phase 1
The Effect of Losartan on Cephalexin
HealthyPossible Interaction Between Losartan and Cephalexin
Aleksi Tornio12 enrolled1 locationNCT07300670